A citation-based method for searching scientific literature

Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands. Diab Vasc Dis Res 2015
Times Cited: 76



Hassan Rahmoune, Paul W Thompson, Joanna M Ward, Chari D Smith, Guizhu Hong, John Brown. Diabetes 2005
Times Cited: 546




List of shared articles



Times cited

Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.
Annabelle M Warren, Søren T Knudsen, Mark E Cooper. Expert Opin Ther Targets 2019
90


SGLT2 inhibitors, an accomplished development in field of medicinal chemistry: an extensive review.
Anirudh Manoj, Subham Das, Anu Kunnath Ramachandran, Angel T Alex, Alex Joseph. Future Med Chem 2020
12


What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.
Jessica A Dominguez Rieg, Timo Rieg. Diabetes Obes Metab 2019
33

Structural Perspectives and Advancement of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes.
Shivani Sharma, Amit Mittal, Shubham Kumar, Anu Mittal. Curr Diabetes Rev 2022
0

A Safety Evaluation of Empagliflozin for the Treatment of Type 2 Diabetes.
Ian J Neeland, Usman Salahuddin, Darren K McGuire. Expert Opin Drug Saf 2016
6


Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistance.
Hideaki Kaneto, Atsushi Obata, Tomohiko Kimura, Masashi Shimoda, Seizo Okauchi, Naoki Shimo, Taka-Aki Matsuoka, Kohei Kaku. J Diabetes 2017
40


SGLT inhibitors as antidiabetic agents: a comprehensive review.
Rahul P Kshirsagar, Abhishek A Kulkarni, Rashmi S Chouthe, Shahebaaz K Pathan, Hemant D Une, G Bhanuprakash Reddy, Prakash V Diwan, Siddique Akber Ansari, Jaiprakash N Sangshetti. RSC Adv 2020
4